Effect of Saline Irrigation in Reducing Choledocholithiasis Recurrence After ERCP
Effect of Intermittent Saline Irrigation in Reducing Choledocholithiasis Recurrence After ERCP
1 other identifier
interventional
180
1 country
1
Brief Summary
In this prospective study, the investigators assessed the utility of intermittent saline irrigation in reducing the recurrent rate of choledocholithiasis after the endoscopic extraction for common bile duct stones, and it does not increase the rate of procedure-related complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2019
CompletedFirst Posted
Study publicly available on registry
May 3, 2019
CompletedStudy Start
First participant enrolled
May 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJanuary 25, 2023
January 1, 2023
3.6 years
May 1, 2019
January 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants with Recurrence of CBD Stones
Number of Participants with stones detected by Magnetic resonance cholangiopancreatography, CT or US confirms CBD stone recurrence no matter symptomatic choledocholithiasis or not
3 years
Secondary Outcomes (5)
Number of Participants with Cholangitis
3 years
Number of Participants with Pancreatitis
3 years
Number of Participants with Bleeding
1 month
Number of Participants with Perforation
1 month
Procedure time of each case
7 days
Study Arms (2)
Saline irrigation
EXPERIMENTALCBD stone removal after routine ERCP procedure,100ml saline irrigation after a balloon occlusion cholangiogram confirming the absence of stones.
None saline irrigation
NO INTERVENTIONCBD stone removal after routine ERCP procedure, a balloon occlusion cholangiogram confirms the absence of stones.
Interventions
100ml saline irrigation after CBD stone removal with routine ERCP procedure
Eligibility Criteria
You may qualify if:
- With ERCP indications
- With mechanical lithotripsy during operation
You may not qualify if:
- Unwillingness or inability to consent for the study
- Unstable vital signs
- Coagulation dysfunction (INR\>1.5) and low peripheral blood platelet count (\<50×10 \^9 / L) or using anti-coagulation drugs
- Prior surgery of Bismuth Ⅱ, Roux-en-Y and cholangiojejunostomy
- Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease (such as decompensated liver cirrhosis, liver failure and so on), septic shock
- Biliary-duodenal fistula confirmed during ERCP
- Pregnant women or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, 730000, China
Related Publications (3)
Ahn DW, Lee SH, Paik WH, Song BJ, Park JM, Kim J, Jeong JB, Hwang JH, Ryu JK, Kim YT. Effects of Saline Irrigation of the Bile Duct to Reduce the Rate of Residual Common Bile Duct Stones: A Multicenter, Prospective, Randomized Study. Am J Gastroenterol. 2018 Apr;113(4):548-555. doi: 10.1038/ajg.2018.21. Epub 2018 Mar 27.
PMID: 29610513BACKGROUNDAng TL, Teo EK, Fock KM, Lyn Tan JY. Are there roles for intraductal US and saline solution irrigation in ensuring complete clearance of common bile duct stones? Gastrointest Endosc. 2009 Jun;69(7):1276-81. doi: 10.1016/j.gie.2008.10.018. Epub 2009 Feb 26.
PMID: 19249039BACKGROUNDLin Y, Yang M, Cao J, Zhang X, Mi N, Yang X, Wang H, Gao L, Bai M, Fu W, Li X, Yue P, Yuan J, Meng W, Leung JW. Saline irrigation for reducing the recurrence of common bile duct stones after lithotripsy: a randomized controlled trial. EClinicalMedicine. 2023 Apr 27;59:101978. doi: 10.1016/j.eclinm.2023.101978. eCollection 2023 May.
PMID: 37152367DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wenbo Meng, MD,PhD
Hepatopancreatobiliary Surgery Institute of Gansu Province
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Ph. D, Direct of surgery
Study Record Dates
First Submitted
May 1, 2019
First Posted
May 3, 2019
Study Start
May 10, 2019
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
January 25, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share